530 related articles for article (PubMed ID: 35964820)
21. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
Front Immunol; 2018; 9():490. PubMed ID: 29593734
[TBL] [Abstract][Full Text] [Related]
22. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
Cui X; Guo YE; Fang JH; Shi CJ; Suo N; Zhang R; Xie X
Acta Pharmacol Sin; 2019 Nov; 40(11):1386-1393. PubMed ID: 30918344
[TBL] [Abstract][Full Text] [Related]
23. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
[TBL] [Abstract][Full Text] [Related]
24. Ursolic Acid Enhances Myelin Repair in Adult Mice Brains and Stimulates Exhausted Oligodendrocyte Progenitors to Remyelinate.
Honarvar F; Hojati V; Zare L; Bakhtiari N; Javan M
J Mol Neurosci; 2022 Oct; 72(10):2081-2093. PubMed ID: 35976486
[TBL] [Abstract][Full Text] [Related]
25. Effect of Sox10 on remyelination of the hippocampus in cuprizone-induced demyelinated mice.
Shao Y; Ding J; He QX; Ma QR; Liu Q; Zhang C; Lv HW; Liu J
Brain Behav; 2020 Jun; 10(6):e01623. PubMed ID: 32363773
[TBL] [Abstract][Full Text] [Related]
26. NEP1-40 alleviates behavioral phenotypes and promote oligodendrocyte progenitor cell differentiation in the hippocampus of cuprizone-induced demyelination mouse model.
Liu Q; Lv HW; Yang S; He YQ; Ma QR; Liu J
Neurosci Lett; 2020 Apr; 725():134872. PubMed ID: 32112820
[TBL] [Abstract][Full Text] [Related]
27. N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination.
Yu X; Cheng G; Zhang L; Zhang Y; Wang Q; Zhao M; Zeng L; Hu Y; Feng L
Sci Rep; 2018 Sep; 8(1):14040. PubMed ID: 30232349
[TBL] [Abstract][Full Text] [Related]
28. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali LN; Hwang Y; Palmisano M; Cuenda A; Sim FJ; Gonzalez A; Volsko C; Dutta R; Trapp BD; Wrabetz L; Feltri ML
Brain; 2024 May; 147(5):1871-1886. PubMed ID: 38128553
[TBL] [Abstract][Full Text] [Related]
29. Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis.
Dupree JL; Paez PM; Tiwari-Woodruff SK; Denton TT; Hensley K; Angeliu CG; Boullerne AI; Kalinin S; Egge S; Cheli VT; Denaroso G; Atkinson KC; Feri M; Feinstein DL
ASN Neuro; 2022; 14():17590914221112352. PubMed ID: 35791633
[TBL] [Abstract][Full Text] [Related]
30. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
Gharagozloo M; Galleguillos D; Jank L; Sotirchos ES; Smith MD; Garton T; Kumar S; Hussein O; Potluri S; Taylor M; Siu C; Mace JW; Dawson T; Dawson VL; Lee S; Calabresi PA
Neurotherapeutics; 2023 Jul; 20(4):1229-1240. PubMed ID: 37296356
[TBL] [Abstract][Full Text] [Related]
31. Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.
Mi G; Gao Y; Liu S; Ye E; Li Y; Jin X; Yang H; Yang Z
Cell Cycle; 2016 Oct; 15(20):2780-91. PubMed ID: 27580304
[TBL] [Abstract][Full Text] [Related]
32. Deletion of Nox4 enhances remyelination following cuprizone-induced demyelination by increasing phagocytic capacity of microglia and macrophages in mice.
Yamanaka K; Nakamura K; Shibahara T; Takashima M; Takaki H; Hidaka M; Komori M; Yoshikawa Y; Wakisaka Y; Ago T; Kitazono T
Glia; 2023 Mar; 71(3):541-559. PubMed ID: 36321558
[TBL] [Abstract][Full Text] [Related]
33. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
[TBL] [Abstract][Full Text] [Related]
34. CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Wang L; Yang H; Zang C; Dong Y; Shang J; Chen J; Wang Y; Liu H; Zhang Z; Xu H; Bao X; Zhang D
Neurobiol Dis; 2020 Feb; 134():104630. PubMed ID: 31678404
[TBL] [Abstract][Full Text] [Related]
35. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
[TBL] [Abstract][Full Text] [Related]
36. The Extracellular Matrix Proteins Tenascin-C and Tenascin-R Retard Oligodendrocyte Precursor Maturation and Myelin Regeneration in a Cuprizone-Induced Long-Term Demyelination Animal Model.
Bauch J; Faissner A
Cells; 2022 May; 11(11):. PubMed ID: 35681468
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-33 has the protective effect on oligodendrocytes against impairment induced by cuprizone intoxication.
Huang HT; Tzeng SF
Neurochem Int; 2024 Jan; 172():105645. PubMed ID: 38016520
[TBL] [Abstract][Full Text] [Related]
38. Icariin ameliorates the cuprizone-induced acute brain demyelination and modulates the number of oligodendrocytes, microglia and astrocytes in the brain of C57BL/6J mice.
Cong H; Liang M; Wang Y; Chang H; Du L; Zhang X; Yin L
Brain Res Bull; 2021 Oct; 175():37-47. PubMed ID: 34274431
[TBL] [Abstract][Full Text] [Related]
39. (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis.
Wang X; Chang L; Wan X; Tan Y; Qu Y; Shan J; Yang Y; Ma L; Hashimoto K
Neurobiol Dis; 2022 Apr; 165():105635. PubMed ID: 35085752
[TBL] [Abstract][Full Text] [Related]
40. The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation.
Willems E; Schepers M; Piccart E; Wolfs E; Hellings N; Ait-Tihyaty M; Vanmierlo T
FASEB J; 2024 Jan; 38(2):e23413. PubMed ID: 38243760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
